Sacral Neuromodulation For Urinary Incontinence

Sacral Neuromodulation For Urinary Incontinence

Our sacral neuromodulation (SNM) treatment pathway for urinary incontinence combines patient eligibility assessment, staged test stimulation, implantable pulse generator options, and post-implantation programming support.
Send Inquiry
Description
Technical Parameters

Our sacral neuromodulation (SNM) treatment pathway for urinary incontinence combines patient eligibility assessment, staged test stimulation, implantable pulse generator options, and post-implantation programming support. Three pulse generator configurations are available in the published device specifications: two non-rechargeable models and one rechargeable model. This allows the treatment team to consider different device configurations when planning treatment for eligible patients.

Clinical Indications for Sacral Neuromodulation

Sacral neuromodulation is a treatment option for selected patients with refractory overactive bladder (OAB), urgency urinary incontinence (UUI), and related bladder dysfunction, particularly when conservative treatment or medication has not provided sufficient improvement or cannot be tolerated.

Potential clinical applications include:

  • Refractory overactive bladder.
  • Urgency urinary incontinence.
  • Persistent urinary urgency and frequency associated with bladder dysfunction.
  • Selected cases of non-obstructive urinary retention, where clinically appropriate.

SNM is not a universal treatment for all types of urinary incontinence. Stress urinary incontinence and other urinary conditions require separate diagnostic assessment and treatment planning.

SNM Patient Eligibility Assessment and Test Stimulation

Patient selection is an essential part of the SNM treatment process. Before permanent implantation, the medical team reviews the patient's symptoms, medical history, previous treatment outcomes, and relevant diagnostic records.

The assessment may include:

  • Urinary symptom history and symptom severity.
  • Previous medication and conservative treatment outcomes.
  • Voiding diaries.
  • Urodynamic examination results, when indicated.
  • Relevant imaging and other diagnostic reports.

Test stimulation is used to evaluate the patient's response before a permanent implant decision.

A commonly used clinical response threshold is at least 50% improvement in relevant symptoms during the test phase. Symptom changes can be documented through voiding diaries and clinical assessment. The exact evaluation criteria depend on the applicable clinical protocol and the treating team's judgment.

Patients who achieve a satisfactory response may proceed to consideration of permanent implantation. Those who do not achieve sufficient improvement require further clinical evaluation rather than automatic progression to implantation.

SNM Treatment Procedure

The sacral neuromodulation treatment pathway includes test stimulation, permanent implantation when clinically appropriate, and subsequent programming and follow-up.

1. Test Stimulation

A test stimulation phase evaluates the patient's response to sacral nerve stimulation. The medical team monitors changes in urinary symptoms and determines whether the response meets the clinical criteria for permanent implantation.

2. Permanent Implantation

For patients who respond satisfactorily to test stimulation, an implantable pulse generator and electrode system may be implanted. The final configuration is determined according to the patient's clinical condition and the treatment team's assessment.

3. Post-Implantation Programming and Follow-Up

After implantation, stimulation parameters can be reviewed and adjusted. Follow-up supports symptom monitoring, programming adjustments, and the management of potential device-related concerns.

Implantable Pulse Generator Options for SNM Treatment

Three implantable pulse generator models are listed in the published SNM device specifications.

Model Dimensions Weight Battery Configuration Stated Warranty
G132 50 × 50 × 6.8 mm 25 g Non-rechargeable, 1850 mAh 2 years
G131 47 × 51 × 10.5 mm 35 g Non-rechargeable, 2500 mAh 2 years
G134R 55 × 52 × 11 mm 36 g Rechargeable 10 years

The G132 and G131 use non-rechargeable batteries, while the G134R has a rechargeable configuration. These differences are relevant when reviewing implant configuration and long-term patient management requirements.

The stated warranty periods refer to the published device specifications. They should not be interpreted as guaranteed battery operating life or a guaranteed replacement interval.

Supporting SNM Equipment and Components

The SNM system includes electrode leads, patient programming equipment, charging components, test stimulation equipment, and clinician programming equipment.

Component Model Published Configuration or Function
Implantable electrode lead L331 Available in L331-28, L331-33, and L331-41
Patient programmer and charger R831 Integrated patient programming and charging
Patient programmer C733 Supports constant-voltage and constant-current stimulation settings
Test stimulation equipment T902 Bluetooth and near-field coupling communication
Clinician programmer PSM1001 Bluetooth communication range of 10 m and near-field coupling

These components support different stages of SNM treatment, from test stimulation to implanted-device programming and patient management. The appropriate configuration should be confirmed against the selected pulse generator and the actual treatment protocol.

Clinical Outcomes and Long-Term Considerations of SNM

Treatment outcomes vary according to patient selection, clinical condition, and response to test stimulation.

Published European clinical guideline evidence reports that, among implanted patients treated for urgency urinary incontinence, at least 50% symptom improvement can be maintained at five years in at least 50% of patients. The same guideline evidence reports that up to approximately 40% may achieve a cure at five years.

Long-term management also requires consideration of device-related interventions. Published clinical evidence reports revision rates commonly around 30–40% within three to four years after implantation in relevant patient populations.

Patients should receive an individual explanation of expected benefits, potential complications, device management requirements, and the possibility of additional procedures. These published outcomes describe clinical populations and do not guarantee an individual patient's response.

Medical Team and International SNM Patient Support

Our medical service pathway supports international patients considering sacral neuromodulation for urinary incontinence through medical record review, preliminary assessment, and treatment planning.

Our published medical team information identifies experience in urology, neuro-urology, and rehabilitation. The team includes Dr. Zhang Yifei, whose clinical experience is stated to exceed 30 years, alongside professionals involved in the assessment of complex urinary disorders.

For preliminary assessment, patients can submit available medical information, including:

  • Medical history and urinary symptom descriptions.
  • Previous treatment records.
  • Urodynamic examination reports, when available.
  • Relevant imaging and diagnostic reports.

According to our published service information, we provide a written remote assessment opinion within 1–3 working days after receiving the required assessment materials. English-language medical communication is also available for international patients.

The preliminary review helps determine whether further clinical consultation is appropriate. Final treatment eligibility, implantation decisions, and procedural arrangements must be established by qualified medical professionals in accordance with the patient's condition and applicable medical regulations.

Request a Sacral Neuromodulation Assessment

If you are considering sacral neuromodulation for urinary incontinence, send us the patient's available medical records, previous treatment information, and relevant examination reports.

Our team can review the submitted information and provide a preliminary assessment of the potential treatment pathway, including patient eligibility, test stimulation, implant configuration, and subsequent treatment arrangements.

 

Hot Tags: sacral neuromodulation for urinary incontinence, China, price, pricelist, quotation, cost, Bowel dysfunction, clinician programmer neurostimulator, neurostimulator programmer, sacral neuromodulation components, sacral neuromodulation stimulation system, SNM stage two permanent implant

Send Inquiry
Send Inquiry